Guidelines for treating patients with diabetes, CKD updated to improve care
Click Here to Manage Email Alerts
The Kidney Disease Improving Global Outcomes updated the clinical practice guidelines for treating patients with diabetes and chronic kidney disease to recommend new practices, according to a press release.
The recommendations include a layered approach to care that addresses lifestyle interventions and first-line pharmacotherapy and the introduction of medications to improve intrarenal hemodynamics. Further, the Kidney Disease Improving Global Outcomes (KDIGO) encourages providers to focus on preserving kidney function and well-being rather than replacing the kidney function.
Another important recommendation was specific to policymakers and institutional decisionmakers to implement team-based and integrated care to improve risk evaluation and empower patients.
KDIGO conducted evidence synthesis and meta-analysis methods to determine these guidelines since December 2021.
According to a press release from KDIGO regarding diabetes in CKD, “The update was motivated by the wealth of high-quality new information that has quickly become available since the 2020 guideline was published and by calls from the community to help guide the application of these new data. The short interval between guidelines reflects the rapid pace of advancement in the treatment of diabetes and CKD.”
Reference:
Diabetes in CKD. https://kdigo.org/guidelines/diabetes-ckd/. Published Jan. 9, 2023. Accessed, Jan. 13, 2023.
Read more about
Click Here to Manage Email Alerts